HomeGMAB • NASDAQ
add
Genmab
$23.43
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$23.43
Sarado: Okt 7, 6:19:27 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$23.49
Sakop ng araw
$23.40 - $23.56
Sakop ng taon
$23.24 - $35.88
Market cap
15.50B USD
Average na Volume
515.32K
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.40B | 29.58% |
Gastos sa pagpapatakbo | 3.40B | 26.72% |
Net na kita | 1.41B | 5.47% |
Net profit margin | 26.06 | -18.61% |
Kita sa bawat share | 21.70 | 5.29% |
EBITDA | 1.88B | 23.85% |
Aktuwal na % ng binabayarang buwis | 33.80% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 15.73B | -36.77% |
Kabuuang asset | 38.62B | 20.77% |
Kabuuang sagutin | 7.65B | 137.36% |
Kabuuang equity | 30.97B | — |
Natitirang share | 63.47M | — |
Presyo para makapag-book | 0.05 | — |
Return on assets | 12.06% | — |
Return on capital | 13.86% | — |
Cash Flow
Net change in cash
| (DKK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.41B | 5.47% |
Cash mula sa mga operasyon | 1.51B | 247.02% |
Cash mula sa pag-invest | -8.77B | -378.04% |
Cash mula sa financing | -3.05B | -43,685.71% |
Net change in cash | -10.34B | -631.19% |
Malayang cash flow | 1.44B | 797.22% |
Tungkol
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US. Wikipedia
Itinatag
1999
Website
Mga Empleyado
2,526
